Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.
Zarski JP, Sturm N, Desmorat H, Melin P, Raabe JJ, Bonny C, Sogni P, Pinta A, Rouanet S, Babany G, Cheveau A, Chevallier M.
Zarski JP, et al. Among authors: melin p.
Liver Int. 2010 Aug;30(7):1049-58. doi: 10.1111/j.1478-3231.2010.02265.x. Epub 2010 May 21.
Liver Int. 2010.
PMID: 20492512
Clinical Trial.
Non-invasive markers analysis did not show any significant change in both groups. CONCLUSION: Long-term therapy with peginterferon alpha-2a did not reduce liver fibrosis degree assessed by morphometry and blood tests as compared with alpha-tocopherol. ...
Non-invasive markers analysis did not show any significant change in both groups. CONCLUSION: Long-term therapy with peginterferon al …